mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.5 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |